Literature DB >> 19544312

Type I IFN regulate DC turnover in vivo.

Fabrizio Mattei1, Laura Bracci, David F Tough, Filippo Belardelli, Giovanna Schiavoni.   

Abstract

DC are the most potent antigen-presenting cells that recognise signs of infection and serve as the main activators of naïve T cells. We have previously shown that type I IFN (IFN-I) are produced by DC and can act in an autocrine manner to activate DC. In the present study, we have investigated the role of IFN-I in regulating the turnover and lifespan of DC. We found that DC, especially the CD8alpha(+) subset, from type I IFN receptor knock out (IFNAR KO) mice, display a reduced turnover rate when compared with DC from WT mice, as revealed by BrdU labelling kinetics. In vitro, IFNAR KO BM precursor cells cultured in the presence of GM-CSF generated CD11c(+) DC less efficiently than WT BM, and the IFNAR KO DC that arose displayed reduced migratory ability. Interestingly, splenic DC from IFNAR KO mice exhibited a higher survival rate in short-term culture compared with control DC. Exposure to IFN-I in vivo markedly increased the turnover rate of splenic DC, particularly CD8alpha(+) DC, which was preceded by a transient induction of apoptosis. In accordance with this, IFN-I stimulated the apoptosis of splenic DC in vitro. Overall, our data indicate that IFN-I are important regulators of DC turnover in vivo and suggest that these cytokines may exert this function through the modulation of multiple processes involving DC apoptosis, proliferation and migration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19544312     DOI: 10.1002/eji.200939233

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Type I interferons: diversity of sources, production pathways and effects on immune responses.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Curr Opin Virol       Date:  2011-11-25       Impact factor: 7.090

2.  Inhibiting mast cell degranulation by HO-1 affects dendritic cell maturation in vitro.

Authors:  Yuan-yuan Ma; Mu-qing Yang; Chun-feng Wang; Jing Ding; Ji-yu Li
Journal:  Inflamm Res       Date:  2014-03-07       Impact factor: 4.575

3.  Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+ T Cell Response by Preventing Type I IFN-Dependent Depletion of Dendritic Cells.

Authors:  Christopher P Loo; Christopher M Snyder; Ann B Hill
Journal:  J Immunol       Date:  2016-11-21       Impact factor: 5.422

4.  IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9.

Authors:  Jui-Hung Yen; Weimin Kong; Doina Ganea
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

5.  Localized delivery of interferon-β by Lactobacillus exacerbates experimental colitis.

Authors:  Adelle P McFarland; Ram Savan; Sagie Wagage; Augustina Addison; Karthika Ramakrishnan; Megan Karwan; Tri Duong; Howard A Young
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

6.  Cutting edge: IFN-γR signaling in non-T cell targets regulates T cell-mediated intestinal inflammation through multiple mechanisms.

Authors:  Jeong-su Do; Kewal Asosingh; William M Baldwin; Booki Min
Journal:  J Immunol       Date:  2014-02-12       Impact factor: 5.422

7.  IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection.

Authors:  Jodi McGill; Nico Van Rooijen; Kevin L Legge
Journal:  J Exp Med       Date:  2010-03-08       Impact factor: 14.307

8.  Immune evasion by Yersinia enterocolitica: differential targeting of dendritic cell subpopulations in vivo.

Authors:  Stella E Autenrieth; Tanja-Rebecca Linzer; Clara Hiller; Birgit Keller; Philipp Warnke; Martin Köberle; Erwin Bohn; Tilo Biedermann; Hans-Jörg Bühring; Günter J Hämmerling; Hans-Georg Rammensee; Ingo B Autenrieth
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

9.  Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1.

Authors:  Juan Qian; Hui Zheng; Wei-Chun Huangfu; Jianghuai Liu; Christopher J Carbone; N Adrian Leu; Darren P Baker; Serge Y Fuchs
Journal:  PLoS Pathog       Date:  2011-06-09       Impact factor: 6.823

10.  E3 ubiquitin ligase CHIP facilitates Toll-like receptor signaling by recruiting and polyubiquitinating Src and atypical PKC{zeta}.

Authors:  Mingjin Yang; Chen Wang; Xuhui Zhu; Songqing Tang; Liyun Shi; Xuetao Cao; Taoyong Chen
Journal:  J Exp Med       Date:  2011-09-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.